We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lichen-Derived Dye May Prevent Alzheimer’s by Neutralizing Toxic Peptides

By LabMedica International staff writers
Posted on 14 Dec 2011
A dye derived from lichens is among the candidate compounds being tested for their ability to convert toxic prefibrillar assemblies of amyloid-beta (A-beta) polypeptides – the cause of neuron death in Alzheimer’s disease – into mature, end-stage amyloid fibrils that are thought to be largely nontoxic.

The dye under consideration by investigators at the Max Delbruck Center for Molecular Medicine (Berlin, Germany) is called O4. This compound is a blue dye that was isolated from lichens together with the reddish-brown dye orcein.

The investigators reported in the November 20, 2011, issue of the journal Nature Chemical Biology that O4 directly bound to hydrophobic amino acid residues in A-beta peptides and stabilized the self-assembly of beta-sheet-rich protofibrils and fibrils. The O4-mediated acceleration of amyloid fibril formation efficiently decreased the concentration of small, toxic A-beta oligomers in complex, heterogeneous aggregation reactions.

O4 treatment suppressed inhibition of long-term potentiation by A-beta oligomers in hippocampal brain slices, results that support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.

“This is a new mechanism,” said senior author Dr. Erich Wanker, professor of neuroproteomics at the Max Delbruck Center for Molecular Medicine. “Up to now it has been considered to be very difficult to stop the formation of small toxic protein assemblies. If our hypothesis is correct that the small aggregates, which are precursors of plaques, indeed cause neuronal death, with O4 we would have a new mechanism to attack the disease. We hope that our findings will stimulate research activities in this direction, especially in drug discovery.”

Related Links:

Max Delbruck Center for Molecular Medicine



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries